Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Environ. Res. Public Health 2009, 6(9), 2510-2525; doi:10.3390/ijerph6092510
Article

A Multicenter, Randomized, Open-Labeled, Parallel Group Trial of Sildenafil in Alcohol-Associated Erectile Dysfunction: The Impact on Psychosocial Outcomes

1,* , 2
, 1
 and 3
Received: 13 August 2009; Accepted: 22 September 2009 / Published: 23 September 2009
(This article belongs to the Special Issue Alcohol and Public Health)
View Full-Text   |   Download PDF [262 KB, uploaded 19 June 2014]   |   Browse Figure
Abstract: To examine the effect of sildenafil on erectile dysfunction (ED) and psychosocial outcomes in alcohol-dependent (AD) men, 108 men with these diagnoses were randomly assigned to either take sildenafil (50 mg) as add-on to standard treatment for AD, or the same treatment without sildenafil, for 12 weeks. Only 50 patients in sildenafil group and 51 in control group twice completed the International Index of Erectile Function (IIEF) and a battery of self-report questionnaires. IIEF scores and psychosocial functioning, self-esteem and support from friends improved only for sildenafil-treated patients (P < 0.001). The high effect sizes suggest that the observed benefits are unlikely to be a placebo effect, although their unspecific nature could not be ruled out. In men with ED associated with AD, sildenafil improves both ED and psychosocial outcomes. Further placebo-controlled clinical trial is warranted.
Keywords: alcohol dependence; erectile dysfunction; sildenafil; depression; functioning; self-esteem; social support alcohol dependence; erectile dysfunction; sildenafil; depression; functioning; self-esteem; social support
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Ponizovsky, A.M.; Averbuch, L.; Radomislensky, I.; Grinshpoon, A. A Multicenter, Randomized, Open-Labeled, Parallel Group Trial of Sildenafil in Alcohol-Associated Erectile Dysfunction: The Impact on Psychosocial Outcomes. Int. J. Environ. Res. Public Health 2009, 6, 2510-2525.

AMA Style

Ponizovsky AM, Averbuch L, Radomislensky I, Grinshpoon A. A Multicenter, Randomized, Open-Labeled, Parallel Group Trial of Sildenafil in Alcohol-Associated Erectile Dysfunction: The Impact on Psychosocial Outcomes. International Journal of Environmental Research and Public Health. 2009; 6(9):2510-2525.

Chicago/Turabian Style

Ponizovsky, Alexander M.; Averbuch, Lev; Radomislensky, Ira; Grinshpoon, Alexander. 2009. "A Multicenter, Randomized, Open-Labeled, Parallel Group Trial of Sildenafil in Alcohol-Associated Erectile Dysfunction: The Impact on Psychosocial Outcomes." Int. J. Environ. Res. Public Health 6, no. 9: 2510-2525.



Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert